Madrid, 14 August, 2017
Mammalian haploid cells, which contain half the number of chromosomes, present problems during mitosis that limit their viability
The removal of the p53 tumour suppressor gene increases the survival rate of these cells thereby stabilising their haploid state
The emergence, in recent years, of the first mammalian haploid cell lines has raised great expectations in the scientific community. Despite their potential, these cultures present some issues that make their use complicated because Haploidy is unstable and can be lost quickly. The Genomic Instability Group at the Spanish National Cancer Research Centre (CNIO) has offered an explanation of this phenomenon and proposes a way to overcome it. Their work has been published this week in the journal Proceedings of the National Academy of Sciences (PNAS).
With the exception of the sperm or ovules, our cells contain two sets of chromosomes, one from each parent. However, organisms with a single set of chromosomes (haploids), such as yeast, are extremely useful for genetic studies and have been crucial in identifying key genes and pathways. The studies on autophagy by Yoshinori Ohsumi, which earned him the Nobel Prize in Medicine in 2016, and the discovery of cell cycle regulatory genes for which Leland Hartwell, Timothy Hunt and Paul Nurse received the same award in 2001, including the research of Elizabeth Blackburn, Carol Greider and Jack Szostak on telomeres, telomerase and its protective effect on the chromosomes, were all made possible thanks to yeast.
"As it has only one set of chromosomes, it is very easy to find interesting mutants as all you have to do is to alter a single allele to produce a phenotype," explains Oscar Fernández-Capetillo, head of the Genomic Instability Group and the leader of the research project. "In mammals, in the absence of haploid cells, other approaches have been used to identify key genes, such as interfering RNA, but they are sub-optimal methods. All this changed five years ago when haploid cells were discovered in a leukaemia patient (KBM7 and HAP1) and with the emergence of techniques to create mammalian haploid embryonic stem cells, developed originally by Anton Wutz," continues Fernández-Capetillo.
These mammalian haploid cells used today to carry out genetic studies present a problem: the cultures become diploid (the normal genetic situation) within a few days. This phenomenon which has been called "diploidization" is what Fernández-Capetillo’s group has been studying. Their findings suggest that the loss of haploid cells is due to their limited viability and, therefore, they are replaced by existing diploid cells in the cultures.
"When you try to isolate haploid cells, it is very difficult to take only one; you usually separate several so you always drag along a diploid. When you culture them, you invariably observe that the haploid cells die and the diploid cells become the majority," explains the author. "We now know that this happens because the haploid cells activate death mechanisms via p53," he adds.
Their studies show that the problem arises when the haploid cells try to separate their chromosomes during mitosis. The machinery involved in cell division has been designed to handle a fixed amount of DNA (46 chromosomes). When there is more (polyploidy) or less (haploidy), mitosis is more prone to errors during the segregation of the chromosomes and this activates p53. This is the reason why haploid cell cultures do not thrive. By eliminating p53, as this study demonstrates, haploid cells are able to survive.
"Our findings should facilitate the use of animal haploid cells, making them accessible to a broader range of laboratories and technologies," the authors conclude. Currently, the group is trying to discover chemical forms of stabilizing haploidy in animal cells and is exploring strategies that would allow the creation of organs or even animals that only have a maternal set of chromosomes.
This work has been funded by Boehringer Ingelheim Fonds, the "La Caixa" Foundation, the Botín Foundation, the Banco Santander through Santander Universities, the Ministry of Economy and Competitiveness (SAF2014-57791.REDC, SAF2014-59498-R, SAF2013-44866-R, SAF2013-49147-P, SAF2016-80874-P) with co-funding from the European Regional Development Fund (ERDF), the Fundació La Marató de TV3, the Howard Hughes Medical Institute and the European Research Council (ERC-617840).
A p53-dependent response limits the viability of mammalian haploid cells. Teresa Olbrich, Cristina Mayor-Ruiz, Maria Vega-Sendino, Sergio Ruiz, Oscar Fernandez-Capetillo, Carmen Gomez, Sagrario Ortega (PNAS 2017). DOI: 10.1073/pnas.1705133114